Research showed that the expression of CDK10 was over-expression in lung adenocarcinoma [24] follicular lymphoma [25] and seminomas [26], and low-expression in breast cancer patients who have poorer prognosis after surgical procedure. Here, CDK10 is linked to breast cancer.